Seeing Is Believing

Currently out of the existing stock ratings of Oliver Reinberg, 2 are a HOLD (40%), 3 are a BUY (60%).
Analyst Oliver Reinberg, currently employed at KEPLER CHEUVREUX, carries an average stock price target met ratio of 33.33% that have a potential upside of 5.59% achieved within 11 days.
Oliver Reinberg’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QGEN, Qiagen NV at 14-Jul-2021.
Analyst best performing recommendations are on QGEN (QIAGEN NV).
The best stock recommendation documented was for QGEN (QIAGEN NV) at 11/14/2019. The price target of $36.31 was fulfilled within 1 day with a profit of $2.14 (6.26%) receiving and performance score of 62.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Nov-2021
$47
$3.67 (8.47%)
$46
15 days ago
(09-Sep-2026)
6/8 (75%)
$4.5 (10.59%)
648
Buy Since 18-Jun-2024
$50
$6.67 (15.39%)
$45
1 months 17 days ago
(07-Aug-2026)
1/4 (25%)
$7.7 (18.20%)
581
Hold Since 29-Apr-2026
$40
$-3.33 (-7.69%)
$38
1 months 17 days ago
(07-Aug-2026)
5/6 (83.33%)
$-2.3 (-5.44%)
108
Hold Since 23-Jun-2026
$42
$2.59 (6.57%)
$48
3 months 1 days ago
(23-Jun-2026)
3/4 (75%)
$4.8 (12.90%)
614
Hold Since 23-Jun-2026
$42
$2.59 (6.57%)
$48
3 months 1 days ago
(23-Jun-2026)
6/9 (66.67%)
$4.8 (12.90%)
430
What Year was the first public recommendation made by Oliver Reinberg?